Concepedia

Robert Bader

RB

Statistics

Publications

3

Citations

136

H-Index

3

Active since

2009

Affiliations

Aptevo Therapeutics (United states)(Current)

Robert Bader is an author at Aptevo Therapeutics (United states) specializing in immunology, immunotherapy, and medicine.

ORCID

Top concepts

Publications per year

2009–2018

3

Publications

3

MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Gabriela Hernández‐Hoyos, Toddy Sewell, Robert Bader et al. · Molecular Cancer Therapeutics · 2016 · 70 citations · Full text

, , +15

CD20-Directed Small Modular Immunopharmaceutical, TRU-015, Depletes Normal and Malignant B Cells

Martha Hayden-Ledbetter, C. Cerveny, Erik Espling et al. · Clinical Cancer Research · 2009 · 46 citations · Full text

Abstract 1786: APVO436, a bispecific anti-CD123 x anti-CD3 ADAPTIR™ molecule for redirected T-cell cytotoxicity, induces potent T-cell activation, proliferation and cytotoxicity with limited cytokine release

Michael R. Comeau, Robert E. Miller, Robert Bader et al. · Cancer Research · 2018 · 20 citations

, , +24

1–3 of 3